Atropine causes diverse and severe effects on NMJ organization. Confocal images of LAL muscles treated twice daily for 7 days with saline or atropine. Preterminal and terminal axons were immunolabeled for neurofilaments and a synaptic vesicle protein, SV2 (green), nAChRs were labeled for α-bungarotoxin (red) and Schwann cells were labeled for S100 (blue). (A), Low-magnification images of saline-, or atropine-treated LAL muscles. In saline-treated muscles, axon terminals (green) precisely overlap brightly labeled nAChRs (red), making NMJs appear Yellow. In atropine-treated muscles, axon terminals sprout (arrows) or retract (arrowheads) and postsynaptic nAChRs are faintly labeled at some NMJs. (B), High magnification images of NMJs showing diverse patterns of synaptic disorganization evoked by atropine. Saline-treated NMJs (e.g., junction 1) show precise alignment of axon terminals (green), tSCs (blue) and postsynaptic clusters of nAChRs (red). In atropine-treated muscles, at some NMJs (e.g., junction 2), nerve terminals extended sprouts (white arrows) that elongated along activated tSC processes (blue arrows), while nAChRs are unaffected. Another set of NMJs (e.g., junction 3) demonstrated selective, profound loss of postsynaptic nAChRs. Other NMJs (e.g., junction 4) displayed selective, complete loss of axon terminals and abnormally quiescent tSCs that formed no processes even in the absence of axon terminals. (C-F), Quantification of diverse effects evoked by atropine at various doses. (C), The percentage of NMJs exhibiting terminal sprouts. (D), The percentage of NMJs exhibiting uniform, profound loss of postsynaptic nAChRs. (E), The percentage of NMJs exhibiting selective loss of terminal arbors. (F), The average diameter of muscle fibers. Atropine-treated muscle fibers are substantially atrophied. *p < 0.01, Scale bar, 30 μm in A, 10 μm in B.